Methicillin-resistant Staphylococcus aureus (MRSA) USA-300 strains have emerged as an important cause of community-acquired infections. These strains have been recognized as an etiology of osteomyelitis but data on their incidence and outcomes are limited. We retrospectively studied the incidence and clinical outcomes of MRSA USA-300 osteomyelitis in patients at the University of Louisville Hospital and the Henry Ford Health System between January 2007 and March 2008. Pulsed-field gel electrophoresis was used to determine USA type. Clinical outcomes were defined as management success versus failure at 12 months. Chi-square tests, Fisher exact tests, and Mann-Whitney tests were used to compare patient characteristics on the basis of clinical outcomes and USA type. Of the 50 patients with MRSA osteomyelitis, 27 (54%) had the USA-300 strain. Clinical failure was identified in 22% (6/27) of the patients with MRSA USA-300 and in 30% (7/23) of the patients with MRSA non-USA-300 osteomyelitis (P = .509). Our results showed that MRSA USA-300 is a significant etiology of MRSA osteomyelitis. With current surgical and medical management, outcomes of patients with MRSA USA-300 osteomyelitis are similar to those of patients with MRSA non-USA-300 osteomyelitis.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Proteomic study of the inhibitory effects of tannic acid on MRSA biofilm.
Front Pharmacol
December 2024
School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Introduction: The mechanism of tannic acid (TA) intervention on methicillin-resistant (MRSA, USA 300) biofilm formation was explored using proteomics.
Methods: The minimum inhibitory concentration (MIC) of TA against the MRSA standard strain USA 300 was determined by two-fold serial dilution of the microbroth. The effects of TA were studied using crystal violet staining.
Novel active Trp- and Arg-rich antimicrobial peptides with high solubility and low red blood cell toxicity designed using machine learning tools.
Int J Antimicrob Agents
January 2025
Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:
Article Synopsis
- * Machine learning techniques were used to identify and rank potential non-hemolytic AMPs from two libraries of peptide sequences, leading to the synthesis and testing of 220 peptides against Methicillin-resistant Staphylococcus aureus (MRSA).
- * Six promising AMPs were further analyzed for their effectiveness against various bacteria and cancer cell lines, revealing a successful strategy for creating effective and safe antimicrobial agents, while also setting a foundation for future research and machine learning applications in peptide design.
Protective effects of immunization with a novel 4 recombinant pore-forming toxoid combination vaccine in a rabbit model of systemic methicillin-resistant infection.
Clin Exp Vaccine Res
October 2024
Research Center, CLIPS BnC, Seoul, Korea.
Purpose: is a Gram-positive bacterium that most frequently acquires antibiotic resistance. As an opportunistic pathogen, it can cause conditions such as bacteremia, sepsis, and myocarditis. Due to the social need for a vaccine against methicillin-resistant (MRSA), many research groups have been designing and studying vaccines for decades.
View Article and Find Full Text PDFHyperimmune Targeting Staphylococcal Toxins Effectively Protect Against USA 300 MRSA Infection in Mouse Bacteremia and Pneumonia Models.
Front Immunol
June 2022
Integrated Biotherapeutics Inc. (IBT), Rockville, MD, United States.
Article Synopsis
- Superbugs like MRSA and VRSA are becoming increasingly resistant to treatment, causing severe infections and posing a major health challenge as there are no FDA-approved vaccines to combat them.
- Recent research focused on developing a vaccine (IBT-V02) that elicited strong immune responses in rabbits against key toxins, showing promising results for future anti-virulence therapies.
- The study demonstrated that both full-length IgG and F(ab') antibody products effectively neutralized multiple toxins and provided protection in models of serious infections, indicating potential for these products in treating life-threatening bacterial infections.
A 3-alkylpyridine-bearing alkaloid exhibits potent antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) with no detectable resistance.
Microbiol Res
August 2022
Laboratório de Microbiologia Médica, Universidade Federal de São João del-Rei (UFSJ), Campus Centro-Oeste Dona Lindu, Divinópolis, Minas Gerais, Brazil.
Staphylococcus aureus is a Gram-positive bacterium responsible for a wide variety of infectious diseases, and its methicillin-resistant isolates pose a serious worldwide public health risk. New drugs are urgently needed for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. Here, we evaluated the antibacterial activity of five 3-alkyl-pyridinic analogs against MRSA and, of these compounds, compound 6 showed promising antibacterial activity against Staphylococcus with minimum inhibitory concentration (MIC) ranging from 0.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!